Data / Drug companies / Maithri Drugs Private Limited
Maithri Drugs Private Limited: 80 products in the FDA NDC directory, labeler code 70600
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Maithri Drugs Private Limited (labeler code 70600) lists 80 products in the FDA National Drug Code Directory. By type: 80 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on February 18, 2026.
The request: Watch Maithri Drugs Private Limited (FDA labeler code 70600): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 70600
- Products in commercial distribution
- 80
- Packages
- 80
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule III 2, Schedule IV 1, Schedule V 1
- Started marketing in the last 12 months
- 3
- Earliest marketing start
- March 31, 2016
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 80 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 80 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 80 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Lithium citrate | 70600-084 | Powder | Bulk ingredients | February 18, 2026 |
| Lithium carbonate | 70600-083 | Powder | Bulk ingredients | February 18, 2026 |
| Sodium bicarbonate | 70600-077 | Powder | Bulk ingredients | December 19, 2025 |
| Cenobamate | 70600-081 | Powder | Bulk ingredients | October 20, 2025 |
| Ivacaftor | 70600-078 | Powder | Bulk ingredients | October 20, 2025 |
| Dibasic potassium phosphate | 70600-075 | Powder | Bulk ingredients | September 20, 2025 |
| Maribavir | 70600-074 | Powder | Bulk ingredients | September 19, 2025 |
| Potassium acetate | 70600-073 | Powder | Bulk ingredients | August 22, 2025 |
| Monobasic potassium phosphate | 70600-076 | Powder | Bulk ingredients | August 14, 2025 |
| Daridorexant hydrochloride | 70600-072 | Powder | Bulk ingredients | July 21, 2025 |
| Magnesium sulfate dried | 70600-071 | Powder | Bulk ingredients | June 20, 2025 |
| Xanomeline tartrate | 70600-069 | Powder | Bulk ingredients | May 20, 2025 |
| Doxycycline monohydrate | 70600-070 | Powder | Bulk ingredients | April 21, 2025 |
| Trospium chloride | 70600-068 | Powder | Bulk ingredients | April 21, 2025 |
| Doxycycline hyclate | 70600-065 | Powder | Bulk ingredients | March 20, 2025 |
| Dibasic sodium phosphate heptahydrate | 70600-044 | Powder | Bulk ingredients | March 3, 2025 |
| Abrocitinib | 70600-064 | Powder | Bulk ingredients | February 18, 2025 |
| Potassium sulfate | 70600-066 | Powder | Bulk ingredients | January 21, 2025 |
| Monobasic sodium phosphate anhydrous | 70600-063 | Powder | Bulk ingredients | December 20, 2024 |
| Sapropterin dihydrochloride | 70600-062 | Powder | Bulk ingredients | November 14, 2024 |
| Vericiguat | 70600-061 | Powder | Bulk ingredients | November 1, 2024 |
| Zinc sulfate heptahydrate | 70600-060 | Powder | Bulk ingredients | August 15, 2024 |
| Finerenone | 70600-059 | Powder | Bulk ingredients | August 15, 2024 |
| Tapinarof | 70600-058 | Powder | Bulk ingredients | July 15, 2024 |
| Dibasic sodium phosphate anhydrous | 70600-057 | Powder | Bulk ingredients | July 15, 2024 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.